Biomarkers for the diagnosis of deep vein thrombosis

Expert Opinion on Medical Diagnostics

Volumn 6, Issue 4, 2012, Pages 253-257

  Coleman, Dawn M ^a   Wakefield, Thomas W ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

D dimer; Deep venous thrombosis; E selectin; Microparticles; P selectin; Venous thromboembolism

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA 2 MACROGLOBULIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 7A; C REACTIVE PROTEIN; D DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; GALECTIN 3 BINDING PROTEIN; INTERLEUKIN 10; MOLECULAR MARKER; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PHOSPHATIDYLSERINE; SELECTIN; THROMBIN; THROMBOPLASTIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANTICOAGULATION; CLINICAL EXAMINATION; DEEP VEIN THROMBOSIS; GOLD STANDARD; HUMAN; INFLAMMATION; LUNG EMBOLISM; MORBIDITY; MORTALITY; NONHUMAN; PREDICTIVE VALUE; RECANALIZATION; RECURRENCE RISK; REVIEW; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; THROMBOGENESIS; ULTRASOUND;

EID: 84863090210     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2012.692674     Document Type: Review

References (31)

1. Heit JA, Cohen A, Anderson FJ. Estimated annual number of incident and recurrent, non-fatal venous thromboembolism (VTE) events in the US. Blood 2005;106:11
2. Rectenwald JE, Myers DD, Hawley AE, et al. D-Dimer, P-Selectin, and microparticles: novel markers to predict deep venous thrombosis. Thromb Haemost 2005;94:1312-17
3. Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol 2008;28:387-91
4. Cosmi B, Legnani C, Cini M, et al. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep venous thrombosis. Thromb Haemost 2005;94:969-74
5. Linkins LA, Choi PO, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism. Ann Intern Med 2006;139:893-900
6. Kurklinsky AK, Kalsi H, Wysokinski WE, et al. Fibrin D-Dimer concentration, deep vein thrombosis symptom duration, and venous thrombus volume. Angiology 2011;62(3):253-6
7. van Mourik JA, Romani de Wit T, Voorberg J. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Cell Biol 2002;117:113-22
8. Frenette PS, Moyna C, Hartwell DW, et al. Platelet-endothelial interactions inflamed mesenteric venules. Blood 1998;91:1318-24
9. Frenette PS, Denis CV, Weiss L, et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000;191:1413-22
10. Mayadas TN, Johnson RC, Rayburn H, et al. Leukocyte rolling and extravasation are severely compromised in P-selectin deficient mice. Cell 1993;74:541-54
11. Ramacciotti E, Blackburn S, Hawley AE, et al. Evaluation of soluble P-Selectin as a marker for the diagnosis of deep venous thrombosis. Clin Appl Thromb Hemost 2011;17(4):425-31
12. del Conde I, Nabi F, Tonda R, et al. Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes. Arterioscler Thromb Vasc Biol 2005;25(5):1065-70
13. Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood 1998;92:4446-52
14. Jilma B, Fasching P, Ruthner C, et al. Hypothesis: is soluble P-selectin a new marker platelet activation? Atherosclerosis 1997;128:135-8
15. Barnes DM, Wakefield TW, Rectenwald JE. Novel biomarkers for deep venous thrombosis: a comprehensive review. Biomark Insights 2008;21(3):93-100
16. Andre P, Hartwell D, Hrachiovinova I, et al. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000;97(25):13835-40
17. Myers DD Jr, Henke PK, Bedard PW, et al. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg 2006;44(3):625-32
18. Gremmel T, Ay C, Seidinger D, et al. Soluble p-selectin, D-dimer and high-sensitivity C-reactive protein after deep vein thrombosis of the lower limb. J Vasc Surg. 2011 Dec;54(6 Suppl):48S-55S
19. Kyrle PA, Hron G, Eichinger S, et al. Circulating p-selectin and the risk of recurrent venous thromboembolism. Thromb Haemost 2007;97:880-3
20. Ay C, Simanek R, Vormittag R, et al. High plasma levels of soluble p-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 2008;112:2703-8
21. Vandy FC, Stabler C, Hawley AE, et al. Soluble P-Selectin for the diagnosis of lower extremity deep venous thrombosis. Presented at the 24th Annual Meeting of the American Venous Forum; February 2012
22. Myers DD, Hawley AE, Farris DM, et al. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg 2003;38:1075-89
23. Jilma B, Kovar F, Hron G, et al. Homozygosity in the single nucleotide polymorphism Ser126Arg in the E-selectin gene associated with recurrent venous thromboembolism. Arch Intern Med 2006;166:1655-9
24. Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003;197:1585-98
25. Goel MS, Diamond SL. Neutrophil enhancement of fibrin deposition under flow through plateletdependent and - independent mechanisms. Arterioscler Thromb Vasc Biol 2001;21:2093-8
26. Rectenwald JE, Myers DD, Hawley AE, et al. D-Dimer, P-Selectin, and microparticles: novel markers to predict deep venous thrombosis. Thromb Haemost 2005;94:1312-17
27. Chirinos JA, Heresi GA, Velasquez H, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005;45(9):1467-71
28. Bucciarelli P, Martinelli I, Artoni A, et al. Circulating microparticles and risk of venous thromboembolism. Thromb Res 2012 May;129(5):591-7
29. Ramacciotti E, Hawley AE, Wrobleski SK, et al. Proteomics of microparticles after deep venous thrombosis. Thromb Res 2010;125(6):e269-74
30. Hron G, Kollars M, Binder B, et al. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 2006;296:397-402
31. Cochery-Nouvellon E, Vitry F, Cornillet-Lefebvre P, et al. Interleukin-10 promoter polymorphism and venous thrombosis-a case control study. ty -45Thromb Haemost 2006;96:24-8